MRNA - THE CEO THAT SOLD - SHARE YOUR FEEDBACKPLEASE READ THE ENTIRE POST, IT MIGHT JUST SAVE YOU A SOUR INVESTMENT
I have been following MRNA for about a month now, and something interesting has happened that not many people know about.
On 4 September, news came out that the CMO, the President AND the CEO have sold large if not all of their holdings.*
Now the company says that this is no reason to panic. (sounds like what we were told about corona in December...)
On the trading platform I use, I have also gotten a notification about insiders selling. This is a built in strategy used along with others to determine the market consensus of the stock (buy, strong buy, hold etc)
We can all probably agree that when head management sell most of their holdings, and not 1 person but 3 senior members, it is generally not a good sign.
Now here is where I'd like your feedback - The large selling off their stocks hasn't been reflecting in the market. In fact, MRNA has been on one long bull run with minor short term bearish chart patterns.
Why would it be that the sell off doesn't reflect in the market?
I personally sold my stock immediately after I saw a report on this from Gurufinder, later confirmed by more mainstream news and other platforms. My opinion is that The company has to portray that they believe their stocks are going all the way up which in this case, selling off massive holdings at the peak tells me that they are taking their profit. Compare this to PFE (Pfizer), whos director INCREASED his holdings. Now that speaks of confidence in the company, right?
* INFO FROM MY TRADING PLATFORM
CEO, SOLD $1,293,810, DATE 18.09.20
PRESIDENT, SOLD $1,228,468, DATE 15.09.20
CMO, SOLD $1,255,321, DATE 15.09.20
Please share your constructive and respectful feedback, and thank you !
Hit like if you found this interesting,
Ev
1MRNA trade ideas
MRNA: Timeline of Clinical Trials; Operation Warp SpeedThis is a timeline of funding related to the US Government's Operation Warp Speed. MRNA and NVAX are the two stocks that have reacted strongly (in both directions) to any kind of COVID news. You can see that towards the end of phase 1 trials, they disclosed grade 3 adverse reactions to the vaccine which led to a -50% drop in the stock.
Is MRNA revealing major upside opportunity? BULL or BEAR? Today we're looking at MRNA aka Moderna, the darling biotech that might be the savior of us all should they produce an mRNA vaccine that could be more easily produced and distributed at scale than a traditional vaccine candidate.
Reading into this story I've been intrigued, especially with the nice patterns forming in this chart with an easy to identify Impulse wave and a correction pattern currently forming. Unfortunately, this is always the riskier proposition and we must consider our Bull and Bear cases objectively so that we have a plan.
As you'll see, we recently bounced off the 0.5 fib retracement from the all-time high of $95 all the way back to $53. Looks like a healthy bounce off that level. But we should almost always expect it. There is nothing to get excited about until we see a more convincing bounce with volume.
While I love the long term pattern being set up in this chart with that hopeful bull target of $136.99, there's a lot of work to make up and resistance to overcome before we get anywhere close. The declining volume is something to watch out for. If you zoom in you'll see the upward channel off the bounce paired with the declining volume. This would indicate that short term we'll retest the low, and if we're lucky we can get a buying opportunity off that low and off the 0.618 at $43.50.
Set your ladders appropriately and always calculate your stop loss according to risk preference fo % loss below average calculated cost. If you plan your buy levels and amount in advance you can easily calculate the average buy price and then subtract 20% for example to reach a reasonable stop loss which shields you from setting a stop loss too high and missing the following run, or setting it too low and losing more than you are willing to.
Meanwhile, looking at the long term trend, we'll have some trading potential on the stock, but need to look for some volatility within the current correction pattern. Given the sharp increase and resulting decrease, one can assume we might see similar moves again in the future, though there's nothing to indicate exactly when at the moment until we see a better channel or a convincing wedge reveal itself.
The longer-term trend bodes well for your everyday investor who's willing to take some loss for a very large potential gain. Should Moderna create their mRNA based vaccine in time and be successful with distribution, the value of this company would quickly skyrocket. I'm willing to bet on an optimistic future and I'm definitely keeping an eye on this opportunity with the buy ladders I've mentioned indicated.
What's your Bull and Bear case on Moderna? How would you play this in the short and long term?
Head & Shoulder Correction: 5th wave $50.03 Target Price1st Wave down from the Top of the Right Shoulder bottoms at $66.88 (today's close) and is equal to a price drop of $16.85. The top of the 4th wave is 66.88 or today's close and the 5th Wave will bring the price down to about $50 where it should find support and consolidate into a wedge established by today's high.
MRNA: 15% slide this week to Buy ZoneMRNA: $49-$51 Slide on pfizer news / Rebound on Wed/Thurs $54
A few thoughts: Pfizer R/D out first thing Monday and I think the news will complete the slide to the support line ($49-51). Should rebound to $54 where it'll have resistance on Wednesday. I think the MRNA R&D news on Thursday will determine a further slide to $44-46 or a big bounce back up to $63
Long term (big picture) is very simpleYou may have seen so many similar charts that look like this before
And this is no difference.
Are you guys very excited to the vaccine?
However, if you like the noise from the news, you would trade this. But news will make your emotions hit the roof.
GL trading!
My word of advice? You'll be trapped in different price. Place ur bet.
Investment Strategy? It will be history. Period.